Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
Background. Parkinson’s disease psychosis (PDP) is a common, nonmotor symptom of Parkinson’s disease (PD), which may affect up to 60% of patients and is associated with impaired quality of life, increased healthcare costs, and nursing home placement, among other adverse outcomes. Characteristic symp...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2021-01-01
|
| Schriftenreihe: | Parkinson's Disease |
| Online-Zugang: | http://dx.doi.org/10.1155/2021/2603641 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
